Skip to Main Content
Mental Health & Behavioral Research, Phase Pilot

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD

What is the purpose of this trial?

Specific Aim 1: As part of a within-subject, two-days, study design, to determine whether acute calcitriol (vs. placebo) pre-treatment is associated with greater amphetamine (Amp)-induced dopamine (DA) release in the caudate, putamen, ventral striatum (VST), and substantia nigra / ventral tegmental area (SN/VTA) of healthy human subjects.

Specific Aim 2: To determine whether acute calcitriol (vs. placebo) pre-treatment is associated with better performance on a test of attention (e.g., the continuous Performance Task or CPT-AX), after treatment with amphetamine. Hypothesis: Investigators hypothesize that Subjects pre-treated with calcitriol will have faster reaction times/higher accuracy on the CPT-AX vs. subjects pre-treated with placebo, after treatment with amphetamine.

  • Trial with
    National Center for Complementary and Integrative Health (NCCIH)
  • Ages
    18 years - 50 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Ben Kazer

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    01/30/2024
  • Study HIC
    #2000020604